Skip to content

AMN Healthcare AMN Cash & Equivalents

Cash & Equivalents at other companies

Doximity logo
DoximityDOCS
$219.18M+4.6%
HealthStream logo
HealthStreamHSTM
$48.71M-37.0%
Tenet Healthcare logo
Tenet HealthcareTHC
$2.97B-1.1%
ARD
Ardent Health PartnersARDT
$609.69M+23.2%
Astrana Health logo
Astrana HealthASTH
$478.38M+85.0%
Cencora logo
CencoraCOR
$2.18B+10.0%

Other financials

Income statement

See full
Revenue$1.4B+99.9%
Gross profit$368.8M+86.2%
Operating income$117.2M+837%
Net income$62.2M+5,793%
EPS (diluted)$1.59+5,400%

Balance sheet

See full
Total debt$776.9M-12.4%
Total equity$712.8M-0.3%
Total assets$2.6B+8.7%

Cash flow

See full
Operating cash flow$562.5M+507%
CapEx$7.2M-27.4%
Free cash flow$555.2M+571%

Valuation

See full
Market cap$1.23B+47.0%
Enterprise value$1.41B-13.3%
P/S0.4×+0.1×

Profitability

See full
Gross margin27.6%-2.5pp
Operating margin-9.8%-14.2pp
Net margin-0.9%-0.4pp
FCF margin20.7%+11.6pp

Returns & leverage

See full
Return on equity-4.5%-2.0pp
Debt / equity1.1×-0.2×
Current ratio1.1×0.0×

Where this comes from

Reported directly by AMN Healthcare in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.

The official record: AMN Healthcare’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about AMN Healthcare's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AMN Healthcare's cash & equivalents?
AMN Healthcare (AMN) reported cash & equivalents of $594.98M in Q1 2026.
How has AMN Healthcare's cash & equivalents changed year-over-year?
AMN Healthcare's cash & equivalents increased by 528.2% year-over-year, from $94.72M to $594.98M.
What is the long-term trend for AMN Healthcare's cash & equivalents?
Over 5 years (2020 to 2025), AMN Healthcare's cash & equivalents has grown at a -4.4% compound annual growth rate (CAGR), from $83.99M to $67.17M.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.